Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Indraprastha Medical Corporation Ltd (INDRAMEDCO) Share Price & Fundamentals

Company Overview

Founded Year

1988

Listed Year

-

Headquarter

New Delhi, India

MD/CEO

Dr. Prathap C. Reddy, Vice Chairman, notable healthcare leader with vast experience in hospital management.

Website

-

Company Facts

What we do

Indraprastha Medical Corporation Ltd offers high-quality, multi-specialty hospital services focused on enhancing patient care through advanced treatments and technology in Delhi, India.

Founded in

1,988

Market share

Leading multispecialty tertiary care hospital with strong presence in organ transplants, cardiology, oncology, neurology, and orthopaedics.

Problem solved

Addresses critical healthcare needs by providing accessible, advanced medical treatments, including robotic surgeries and multi-organ transplants.

Top clients or who we serve

Catering primarily to B2C patients needing tertiary and super-specialty medical care nationally and internationally.

Key management

Dr. Prathap C. Reddy, Vice Chairman, notable healthcare leader with vast experience in hospital management.

Our journey and innovations

Pioneered robotic surgeries, first corporate hospital in India, multiple organ transplant units, advanced radiation therapies, and digital health initiatives since 1988.

Where we operate

Operates mainly in Delhi and Noida, with international patient referrals and telemedicine ties with Central Asia regions.

Top products or what we offer

Comprehensive hospital care with specialties in multi-organ transplants, robotic surgeries, cardiology, oncology, and emergency services.

Top brands

Indraprastha Apollo Hospitals, Apollo Chest Pain Centre, Apollo Institute of Robotic Surgery, Apollo Obesity and Metabolic Surgery Centre.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from recurring patient services with steady demand for elective and emergency healthcare treatments.

Our industry position

Among top multispecialty hospitals in Delhi with JCI accreditation and recognized for clinical excellence and innovation.

Financial highlights

FY 2024-25 revenue Rs 1356 crore; profit after tax Rs 161 crore; 9% revenue and 30% profit growth year-on-year.

Geographical revenue split

-

Order book

-

Whats driving growth

Innovation in robotic surgeries, expanded transplant services, infrastructure upgrades, and increased patient inflow drive growth.

Our future plans

Expand advanced clinical programs, upgrade technology, and improve patient experience through infrastructural revamps and sustainability.

Our green promise

Implemented biomethanation plant converting hospital waste into biogas and organic manure showcasing commitment to sustainability.

Our people and values

Focus on expert clinicians and staff accompanied by policies ensuring workplace safety and ethical practices.

Key challenges ahead

Regulatory compliance, managing free treatment mandates, and maintaining quality amid expanding services.

Interesting facts

First in India with robotic left lateral donor hepatectomy and first South Asia use of Zap-X radiosurgery system.

Risks and strategy

Mitigates risks via strict governance, continual technological upgrades, and compliance with legal and medical standards.

Market Footprint

Top Clients

Top Clients

Catering primarily to B2C patients needing tertiary and super-specialty medical care nationally and internationally.

Top Products

Top Products

Comprehensive hospital care with specialties in multi-organ transplants, robotic surgeries, cardiology, oncology, and emergency services.

Price Movement & Share Holding

Today's High/Low

311.8320.9

52 Week High/Low

293.65640.85
Past Returns

1 week

1.13%

1 month

-12.89%

3 month

-15.08%

1 year

-44.39%

3 year

95.57%

5 year

328.42%

Share Holding

Promoters

51%

FII

2.39%

DII

1.76%

Retail

36.05%

Others

8.8%

Company Overview

Founded Year

1988

Listed Year

-

Headquarter

New Delhi, India

MD/CEO

Dr. Prathap C. Reddy

Website

-

Price Movement & Share Holding

Today's High/Low

311.8320.9

52 Week High/Low

293.65640.85

Past Returns

1 week

1.13%

1 month

-12.89%

3 month

-15.08%

1 year

-44.39%

3 year

95.57%

5 year

328.42%

Share Holding

Promoters

51%

FII

2.39%

DII

1.76%

Retail

36.05%

Others

8.8%

Company Facts

What we do

Indraprastha Medical Corporation Ltd offers high-quality, multi-specialty hospital services focused on enhancing patient care through advanced treatments and technology in Delhi, India.

Founded in

1988

Market share

Leading multispecialty tertiary care hospital with strong presence in organ transplants, cardiology, oncology, neurology, and orthopaedics.

Problem solved

Addresses critical healthcare needs by providing accessible, advanced medical treatments, including robotic surgeries and multi-organ transplants.

Top clients or who we serve

Catering primarily to B2C patients needing tertiary and super-specialty medical care nationally and internationally.

Key management

Dr. Prathap C. Reddy, Vice Chairman, notable healthcare leader with vast experience in hospital management.

Our journey and innovations

Pioneered robotic surgeries, first corporate hospital in India, multiple organ transplant units, advanced radiation therapies, and digital health initiatives since 1988.

Where we operate

Operates mainly in Delhi and Noida, with international patient referrals and telemedicine ties with Central Asia regions.

Top products or what we offer

Comprehensive hospital care with specialties in multi-organ transplants, robotic surgeries, cardiology, oncology, and emergency services.

Top brands

Indraprastha Apollo Hospitals, Apollo Chest Pain Centre, Apollo Institute of Robotic Surgery, Apollo Obesity and Metabolic Surgery Centre.

Recurring vs cyclical contribution

Revenue primarily from recurring patient services with steady demand for elective and emergency healthcare treatments.

Our industry position

Among top multispecialty hospitals in Delhi with JCI accreditation and recognized for clinical excellence and innovation.

Financial highlights

FY 2024-25 revenue Rs 1356 crore; profit after tax Rs 161 crore; 9% revenue and 30% profit growth year-on-year.

Whats driving growth

Innovation in robotic surgeries, expanded transplant services, infrastructure upgrades, and increased patient inflow drive growth.

Our future plans

Expand advanced clinical programs, upgrade technology, and improve patient experience through infrastructural revamps and sustainability.

Our green promise

Implemented biomethanation plant converting hospital waste into biogas and organic manure showcasing commitment to sustainability.

Our people and values

Focus on expert clinicians and staff accompanied by policies ensuring workplace safety and ethical practices.

Key challenges ahead

Regulatory compliance, managing free treatment mandates, and maintaining quality amid expanding services.

Interesting facts

First in India with robotic left lateral donor hepatectomy and first South Asia use of Zap-X radiosurgery system.

Risks and strategy

Mitigates risks via strict governance, continual technological upgrades, and compliance with legal and medical standards.

Market Footprint

Top Clients

Top Clients

Catering primarily to B2C patients needing tertiary and super-specialty medical care nationally and internationally.

Top Products

Top Products

Comprehensive hospital care with specialties in multi-organ transplants, robotic surgeries, cardiology, oncology, and emergency services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions